If you have been reading about LC-MS/MS and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-09-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Pharmaceutical formulation, in pharmaceutics, is the process in which the active drug or Active Pharmaceutical Ingredient (API) is combined with different chemical substances to produce a final medicinal product. The word formulation is often used in a way that includes dosage form.
In May 2010, Robinson won the Republican primary for Oregon's 4th congressional district, taking 79% of the vote to businesswoman Jaynee Germond's 20%. He faced Democratic incumbent Peter DeFazio in the November 2010 general election. Six weeks before the election, $600,000 worth of TV advertisements started to appear in the district, portraying his opponent as "a puppet of the Democratic leadership". It was later revealed that the advertisements, reportedly a surprise to Robinson, were paid for by conservative billionaire hedge fund manager Robert Mercer. (Mercer provided "six-figure financial support" to Robinson again in 2012 and 2014.) Robinson was defeated by 145,091 votes (53.6%) to 120,307 (44.5%) but it was the "best performance" by a Republican in the district "in decades". Robinson vowed to try again in 2012.
==== Obsessive–compulsive disorder ==== Clomipramine was the first drug that was investigated for and found to be effective in the treatment of OCD. In addition, it was the first drug to be approved by the FDATooltip Food and Drug Administration in the United States for the treatment of OCD. The effectiveness of clomipramine in the treatment of OCD is far greater than that of other TCAs, which are comparatively weak SRIs; a meta-analysis found pre- versus post-treatment effect sizes of 1.55 for clomipramine relative to a range of 0.67 for imipramine and 0.11 for desipramine. In contrast to other TCAs, studies have found that clomipramine and SSRIs, which are more selective SRIs, have similar effectiveness in the treatment of OCD. However, multiple meta-analyses have found that clomipramine nonetheless retains a significant effectiveness advantage relative to SSRIs; in the same meta-analysis mentioned previously, the effect sizes of SSRIs in the treatment of OCD ranged from 0.81 for fluoxetine to 1.36 for sertraline (relative to 1.55 for clomipramine). In a 2025 meta-analysis of trials in children and adolescents, clomipramine was shown to lower OCD symptoms more than a sugar pill by an average of about 4.5 points on the standard rating scale. However, the effectiveness advantage for clomipramine has not been apparent in head-to-head comparisons of clomipramine versus SSRIs for OCD. The differences in effectiveness findings could be due to differences in methodologies across non-head-to-head studies.
=== Pharmacokinetics === After ingestion, bisoprolol is absorbed and has a high bioavailability of approximately 90% with a plasma half-life of 10–12 hours. Typically, half the circulating bisoprolol is metabolized by the liver, the rest passing unchanged through the kidneys before elimination; less than 2% may be excreted in the feces. Bisoprolol is soluble in both lipids and water. It is classified as a beta blocker with moderate lipophilicity and hence intermediate potential for crossing the blood–brain barrier. This in turn may result in fewer effects in the central nervous system as well as a lower risk of neuropsychiatric side effects than highly lipophilic beta blockers like propranolol but greater such effects than beta blockers with low lipophilicity like atenolol. The plasma protein binding of bisoprolol is approximately 35%, the volume of distribution is 3.5 L/kg and the total clearance is approximately 15 L/h. Bisoprolol is eliminated from the body in two ways - 50% of the substance is converted in the liver to inactive metabolites, which are then excreted in the kidneys. The remaining 50% is eliminated unchanged via the kidneys. Since elimination is equal in liver and kidney, no dose adjustment is required in patients with hepatic or renal impairment. The pharmacokinetics of bisoprolol are linear and independent of age. In patients with chronic heart failure, the plasma level of bisoprolol is higher and the half-life is longer than in healthy subjects when compared across studies.
Sources: en.wikipedia.org
Cephalosporins are synthesised from the same biochemical pathway as penicillin biosynthesis, but requires two additional enzymes (such as deacetoxycephalosporin C synthase/hydroxylase and deacetylcephalosporin C acetyltransferase) which are absent in P. rubens. However, P. rubens is genetically engineered to produce the antibiotics by activating the specific genes (cefEF and cefG) that led to the production of the essential enzymes.
The Office of the Cayman Island's Governor stated that the British government "recognizes the importance of regional security and is committed to providing advice and capacity building to our Cayman law-enforcement partners", highlighted the mutual defense alliance between the British and American governments, and emphasized organized crime as a common threat. The United States maintains two Forward Operating Locations (FOL) on the Dutch territories of Aruba and Curaçao, stemming from a 2000 treaty. In response to escalating tensions between Venezuela and the US, the Dutch have taken a neutral position, but say treaties must be honored. Dutch Defense Minister Ruben Brekelmans stated that the treaty "permits flights from Curaçao solely for surveillance, monitoring, and the detection of drug shipments. This consent applies only to unarmed flights". According to the Curacao Chronicle, the minister indicated that the approximate 1,000 soldiers in the Dutch Antilles, as well as the Dutch Caribbean Coast Guard and accompanying aircraft, could be used "if the situation escalates". On 19 September, Prime Minister Gilmar Pisas of Curaçao stated it would renew its treaty for the Curaçao-based FOL until at least 2 November 2026. The US expressed interest in establishing a temporary military radar base in Grenada in October. Critics urged Prime Minister Dickon Mitchell to deny the request, as they feared that the US strikes were a pretext for war with Venezuela, a nation that they say "has not done ... anything" to Grenada.
=== Photobiont === The photobiont partner of Parmotrema perlatum is from Trebouxia, a green algal genus belonging to the order Trebouxiales (order Chlorophyta). It has been identified as an undescribed species within a clade containing Trebouxia arboricola. A study compared the desiccation tolerance and physiological responses of lichenised Trebouxia to isolated cultures of the same alga. Both forms can survive extended desiccation, but with differing responses to photo-oxidative stress. Lichenisation enhances the photoprotective mechanisms of Trebouxia, improving quenching of excess light energy, particularly under high relative humidity, and controlling reactive oxygen species production under light exposure. However, isolated cultures showed better photosynthetic performance after desiccation recovery. This research demonstrates the mutual benefits of the lichen-photobiont partnership, where the alga gains a sheltered environment boosting its resilience to environmental stressors. Further studies on Parmotrema perlatum revealed specific antioxidant mechanisms supporting its photobiont under stress. The lichen shows high levels of reactive oxygen species scavenging enzymes such as superoxide dismutase and ascorbate peroxidase, protecting the photobiont from oxidative damage during dehydration and rehydration cycles. This enhanced antioxidant system provides not only physical shelter but also biochemical protection, increasing the photobiont's resilience to environmental fluctuations.
The dynamics of an epidemic, for example, the flu, are often much faster than the dynamics of birth and death, therefore, birth and death are often omitted in simple compartmental models. The SIR system without so-called vital dynamics (birth and death, sometimes called demography) described above can be expressed by the following system of ordinary differential equations:
Severity of injury found on imaging will determine whether the surgeon takes an operative or close observational approach. Diagnostic peritoneal lavage (DPL) has become largely obsolete with the advances in MDCT, with use limited to centers without access to CT to guide requirement for urgent transfer for operation.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.